Solitary lymph node recurrence
Conditions
Interventions
None listed
Sponsors
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology
Gunma University Heavy Ion Medical Center Hyogo Ion Beam Medical Center Ion Beam Therapy Center, SAGA HIMAT Foundation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Among patients who underwent carbon-ion radiotherapy in participating facilities between December 1996 and December 2015, patients who meet the following eligible criteria. 1) Patients who had diagnosed histologically or clinically as solitary lymph node recurrence. 2) Recurrence in single one lymph node region. 3) Lymph node recurrence could be included in an irradiation field. 4) There are no other recurrent lesions except the lymph node recurrence. 5) Tumor diameter could be measured by CT or MRI. 6) The age at starting of the carbon-ion radiotherapy was 20 years old and older. 7) Carbon-ion radiotherapy was administered to the lymph node recurrence.
Exclusion criteria
Exclusion criteria: 1)Tumor invasion to GI tract. 2)Severe or active nfections in the irradiated area. 3)Severe concomitant illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2-year local control, course-specfic survival, and overall survival rates. Incidence of Grade 2 or worse late toxicities | — |
Countries
Japan
Contacts
Public ContactOkonogi Okonogi
National Institutes for Quantum and Radiological Sciences and Technology Hospital of the National Institute of Radiological Sciences
Outcome results
None listed